May. 6, 2019
Vestaron announces that Jessica Vanhoy will be joining the company as Chief Financial Officer. Most recently Director of Financial Planning and Analysis for Dova Pharmaceuticals, Jessica has 20 years' experience in accounting and finance, fostering team work through company growth. She holds a BSBA in Accounting from Appalachian State University, an MBA from Campbell University, and is a certified public accountant in the state of North Carolina.
"As the organization continues to transition from an R&D focused company to a commercial one, the role of CFO is vital," explains Anna Rath, Vestaron's CEO. "We look forward to Jessica joining the team as she brings outstanding capabilities in using financial planning and analysis to partner with the business and drive results."
"With the recent receipt of a new mode of action code from the Insecticide Resistance Action Committee and potential peptide molecules in development, it is an exciting time to become the newest Vestaron employee," shares Vanhoy.
About Vestaron Corporation
Vestaron is a company dedicated to improving the safety, efficacy and sustainability of crop protection through displacement of chemical pesticides with biological peptides. Vestaron is initially focused on a class of peptides that kills insect pests efficiently, but is safe for humans, birds, fish and the environment. As part of this, the company has developed fermentation-based peptide production and insect resistant crop platform that will allow it to develop a wide variety of biologic crop protection and trait products. More information at www.vestaron.com